Results 191 to 200 of about 52,862 (295)

Long‐Term Determinants of Lean Mass in Ageing Adults: A 17‐Year Longitudinal Cohort Study With Repeated Measures

open access: yesAustralasian Journal on Ageing, Volume 45, Issue 4, December 2026.
ABSTRACT Objective Age‐related loss of lean mass is a hallmark of sarcopenia and a contributor to functional decline and morbidity in ageing populations. This study aimed to identify long‐term determinants of lean mass during ageing. Methods Data from 3033 participants (ages 20–96 years; 49% women) in the Geelong Osteoporosis Study were analysed using ...
Aminu Suleiman   +6 more
wiley   +1 more source

Gastric Cancer: Epidemiology, Risk Factors, Pathogenesis, Clinical Features, Diagnosis, and Management

open access: yesMedComm, Volume 7, Issue 11, November 2026.
This comprehensive review summarizes gastric cancer epidemiology, multifactorial risk factors (like infectious, dietary, genetic), pathogenesis such as precancerous evolution, molecular alterations, and a focus on the bidirectional interactions between gastric cancer cells and macrophages in the tumor microenvironment.
Yixuan Xin   +6 more
wiley   +1 more source

Impact of COVID‐19 Restrictions on Estimating Causal Effects: Fluoroquinolones and Tendon Rupture

open access: yesPharmacoepidemiology and Drug Safety, Volume 35, Issue 11, November 2026.
ABSTRACT Purpose The COVID‐19 pandemic disrupted healthcare services, potentially affecting causal effect estimation using real‐world data. As a case study, we replicated a cohort study using Clinical Practice Research Datalink Aurum to evaluate whether pandemic‐related disruptions influenced the measured association between fluoroquinolone use and ...
Angel Y. S. Wong   +7 more
wiley   +1 more source

Evaluation of triplet therapy combined with robot‐assisted cytoreductive prostatectomy for high‐volume metastatic prostate cancer: a multicentre randomised controlled trial protocol

open access: yesBJU International, Volume 138, Issue 5, Page 807-814, November 2026.
Background Prostate cancer (PCa) is the second most common cancer in men. For patients with high‐volume metastatic PCa (mPCa) who are fit for docetaxel, a triplet therapy regimen consisting of androgen deprivation therapy (ADT), chemotherapy, and an androgen receptor pathway inhibitor (ARPI) is recommended.
Xiangwei Yang   +7 more
wiley   +1 more source

Changes of Periodontal Conditions of First and Second Molars With Furcation Involvement Grade II or III ‐ a Retrospective Analysis of 14 to 17 Year Follow‐up

open access: yesInternational Journal of Dental Hygiene, Volume 24, Issue 4, Page 568-580, November 2026.
ABSTRACT Objective This retrospective analysis aimed to evaluate the clinical changes and survival rate of first and second molars with furcation involvement (F‐Inv) grades II and III after completion of non‐surgical active periodontal therapy (APT) and subsequent supportive periodontal therapy (SPT), with a minimum follow‐up period of 14 years ...
Ayisha Gangadin   +2 more
wiley   +1 more source

Characterizing bone metastases and skeletal‐related events in patients with well‐differentiated neuroendocrine neoplasms utilizing 68Gallium‐DOTATATE positron emission tomography

open access: yesJournal of Neuroendocrinology, Volume 38, Issue 11, November 2026.
Abstract Tumors of neuroendocrine origin are a heterogenous group of related neoplasms which can arise from anywhere in the body. Neuroendocrine neoplasms (NENs) are categorized by site of origin, differentiation status and grade (Ki‐67 expression and/or mitotic rate), with significant prognostic variability accordingly. Historically, the prevalence of
Tucker W. Coston   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy